Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06722391 · ClinicalTrials.gov registry record · NA
Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism
A NA study of Insulin Resistance, sponsored by University of Texas, El Paso.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06722391: Recruiting NA study of Insulin Resistance, sponsored by University of Texas, El Paso.
NCT06722391 is a NA study of Insulin Resistance that is actively recruiting participants, run by University of Texas, El Paso. The registered enrollment target is 80 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06722391, a NA study of Insulin Resistance, is actively recruiting participants, sponsored by University of Texas, El Paso.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Once written consent is obtained, the participant will be provided with an accelerometer to be worn for 7 days to assess current physical activity levels. Subjects will be provided with a standardized diet (55/15/30% CHO/PRO/FAT) prior to collection of pre-intervention data of insulin sensitivity. Individuals will then participate in an 8-week electrical stimulation intervention (30min/day, 3x/week) and randomized into placebo/control, NMES, resistance training combined with NMES (RT +NMES), or resistance training (RT) group (n=20 per group), followed by collection of post-intervention data. The control group will receive electrical stimulation up to sensory level, the NMES group will receive stimulation up to tolerable intensity to induce visible muscle contraction, the RT+ NMES will receive stimulation up to tolerable intensity during resistance training, and the RT group will only receive exercise training. Control and NMES group will self administer stimulation at home. Pre-and post-intervention data includes measurements for body composition, resting metabolic rate, VO2max, insulin sensitivity, and comprehensive blood work.
Primary Outcome
Insulin Sensitivity will be measured through repeated blood sampling during an Oral Glucose Tolerance Test and Continuous Glucose Monitoring
Conditions Studied
Interventions
- DEVICE Neuromuscular Electrical Stimulation (Sensory)
- DEVICE Neuromuscular Electrical Stimulation
- OTHER Resistance Training
Study Locations (1)
Texas
- University of Texas at El Paso - El Paso
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-08-19 |
| Est. Completion | 2031-09-01 |
| Phase | NA |
What NCT06722391 shows while recruiting
NCT06722391 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Insulin Resistance appearing as the primary indexed condition, and to 3 interventions - of which Neuromuscular Electrical Stimulation (Sensory) is the first listed.
NCT06722391 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06722391 about?
NCT06722391 is a clinical study titled "Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism". Once written consent is obtained, the participant will be provided with an accelerometer to be worn for 7 days to assess current physical activity levels. Subjects will be provided with a standardized diet (55/15/30% CHO/PRO/FAT) prior to collection of pre-intervention data of insulin sensitivity. I...
What is the current status of trial NCT06722391?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-08-19. Estimated completion is 2031-09-01.
What conditions does trial NCT06722391 study?
This clinical trial studies the following conditions: Insulin Resistance.
What interventions are being tested in trial NCT06722391?
The interventions under investigation include: Neuromuscular Electrical Stimulation (Sensory) (DEVICE), Neuromuscular Electrical Stimulation (DEVICE), Resistance Training (OTHER).
Who is sponsoring clinical trial NCT06722391?
This trial is sponsored by University of Texas, El Paso, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06722391 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06722391's enrollment target sits among peer trials
80 31st of 120 higher than 88 of 120 other Insulin Resistance trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insulin Resistance trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Small Extracellular Vesicles and Insulin Action
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
New Mechanisms of Obesity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI